Jeevan Scientific Technology Limited engages in the clinical research and data management businesses in India. The company's services include BA/BE studies that comprise bioanalytical and clinical services, pharmacokinetic and bio-statistics, and glucose clamping; clinical trial services, such as medical writing, clinical trial management and monitoring, drug safety, clinical data management, biostatistics and statistical programming, and quality assurance; and pharmacovigilance services, including ICSR management, aggregate safety reports, risk management plan, signal detection, medical information call center, and other integrated services. It also exports its products. The company was formerly known as Jeevan Softech Limited and changed its name to Jeevan Scientific Technology Limited in March 2011. Jeevan Scientific Technology Limited was incorporated in 1999 and is based in Hyderabad, India.
Rs. Crores · hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales 16.93
18.38
16.91
10.43
8.22
8.92
11.87
10.30
12.52
9.92
10.13
8.06
10.39
Expenses 13.28
14.91
12.26
8.96
9.34
9.83
9.83
8.35
9.13
9.37
9.03
7.39
8.35
Operating Profit 3.65
3.47
4.65
1.47
-1.12
-0.91
2.04
1.95
3.39
0.55
1.10
0.67
2.04
OPM % 21.56
18.88
27.50
14.09
-13.63
-10.20
17.19
18.93
27.08
5.54
10.86
8.31
19.63
Other Income 0.26
0.37
0.18
0.26
0.38
0.14
0.22
0.16
0.11
0.25
-0.12
0.26
0.30
Depreciation 1.43
1.36
1.35
1.45
1.50
1.53
1.23
1.25
1.28
1.41
1.35
1.38
1.42
Interest 0.30
0.25
0.38
0.38
0.36
0.35
0.26
0.27
0.15
0.16
0.13
0.25
0.19
Profit before tax 2.18
2.23
3.10
-0.10
-2.60
-2.65
0.77
0.59
2.07
-0.77
-0.50
-0.70
0.73
Tax % 13.76
28.70
25.81
-10.00
-16.54
-49.43
57.14
74.58
22.71
-3.90
-22.00
-27.14
20.55
Net Profit 1.89
1.59
2.30
-0.09
-2.16
-1.34
0.32
0.15
1.60
-0.74
-0.39
-0.50
0.58
EPS in Rs 0.94
0.80
1.45
-0.06
-1.36
-0.85
0.20
0.10
1.03
-0.48
-0.25
-0.32
0.37
Annual · Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
53.93 43.61 38.50 36.18 56.55 40.42 20.57 25.43 19.25 17.46 17.34 13.45
Expenses
45.45 37.08 34.12 34.83 39.46 23.79 26.35 19.62 15.93 14.24 15.15 11.10
Operating Profit
8.48 6.53 4.38 1.35 17.09 16.63 -5.78 5.81 3.32 3.22 2.19 2.35
OPM %
15.72 14.97 11.38 3.73 30.22 41.14 -28.10 22.85 17.25 18.44 12.63 17.47
Other Income
1.19 0.63 0.69 1.06 5.90 2.38 2.49 0.97 0.90 0.57 0.40 0.10
Interest
1.38 1.10 0.75 1.01 0.96 1.88 2.57 2.09 1.67 1.48 1.28 0.74
Depreciation
5.65 5.29 5.55 5.02 3.68 3.96 3.91 3.07 2.06 1.18 0.67 0.28
Profit before tax
2.64 0.77 -1.23 -3.62 18.35 13.17 -9.77 1.62 0.49 1.13 0.64 1.43
Tax %
37.50 3.90 -14.63 -16.85 33.19 14.58 -20.06 16.05 46.94 8.85 34.38 0.00
Net Profit
1.65 0.74 -1.05 -3.00 12.26 11.26 -7.81 1.36 0.25 1.03 0.42 1.44
EPS in Rs
0.83 0.47 -0.68 -1.94 8.01 7.36 -5.10 0.89 0.22 1.11 0.70 2.38
Dividend Payout %
0.00 0.00 0.00 0.00 14.98 6.79 0.00 0.00 0.00 0.00 0.00 0.00
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
19.92 15.83 15.48 15.48 15.30 15.30 15.30 15.30 11.46 9.28 6.04 6.04
Reserves
53.38 35.08 33.32 32.84 35.28 20.95 9.63 17.47 11.24 8.15 -1.85 -2.26
Borrowings
14.94 12.88 5.80 8.84 12.55 10.34 17.95 18.15 18.78 8.45 11.08 6.42
Other Liabilities
11.01 6.83 5.32 6.59 14.75 17.18 10.00 9.90 7.82 5.10 5.30 6.75
Total Liabilities
99.25 70.62 59.92 63.75 77.88 63.77 52.88 60.82 49.30 30.98 20.57 16.95
Fixed Assets
30.92 28.72 20.20 24.03 19.07 20.53 23.69 26.61 23.79 13.83 8.60 1.16
CWIP
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.59
Investments
5.00 2.00 2.00 2.00 0.00 1.03 1.03 1.03 1.03 0.53 0.53 0.00
Other Assets
63.33 39.90 37.72 37.72 58.81 42.21 28.16 33.18 24.48 16.62 11.44 11.20
Total Assets
99.25 70.62 59.92 63.75 77.88 63.77 52.88 60.82 49.30 30.98 20.57 16.95
Annual · Rs. Crores — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
2.56 2.96 2.74 -6.29 19.56 4.73 -1.19 2.41 3.73 -8.13 3.95 2.39
Cash from Investing Activity
-13.92 -9.84 -4.69 -7.27 -1.20 -0.80 -1.02 -6.20 -12.43 -6.41 -4.07 -4.59
Cash from Financing Activity
20.62 6.58 -3.66 -10.03 5.67 -0.13 0.44 6.07 9.88 14.57 0.23 2.21
Net Cash Flow
9.26 -0.30 -5.61 -23.59 24.03 3.80 -1.77 2.28 1.18 0.03 0.11 0.01
Free Cash Flow
-8.79 -7.34 -2.48 -12.55 17.33 3.93 -2.20 -3.79 -8.71 -14.54 0.40 -2.20
CFO/OP %
29.00 43.00 103.00 -262.00 150.00 40.00 54.00 41.00 112.00 -252.00 180.00 102.00
Annual · Days / % — latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
125.41 120.44 113.10 117.83 49.12 112.52 106.47 208.26 305.65 232.25 152.19 199.19
Inventory Days
132.65 93.00 100.18 105.50 72.11 — — — — — — —
Days Payable
431.74 273.00 184.48 318.92 98.78 — — — — — — —
Cash Conversion Cycle
-173.67 -59.56 28.80 -95.59 22.45 112.52 106.47 208.26 305.65 232.25 152.19 199.19
Working Capital Days
167.78 166.89 147.42 114.91 12.20 52.74 -88.54 13.06 47.97 97.84 52.41 32.02
ROCE %
5.29 3.14 -0.86 -4.34 27.85 33.64 -15.29 8.03 6.41 12.69 15.08 25.71
% holding — latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
30.25
30.25
38.05
38.05
38.05
38.05
37.84
38.70
38.70
38.70
38.48
38.48
Public
69.76
69.75
61.96
61.95
61.96
61.96
62.17
61.31
61.29
61.29
61.51
61.51
No. of Shareholders
4,966
5,053
5,159
5,444
5,460
5,497
5,565
5,607
5,655
5,749
5,727
5,933
2 records